Site Map
Search
Site Outline
Home
Company
Overview
Mission
History
Focus Areas
Patents and Trademarks
Management Team
Board of Directors
Technology
Nanoparticles
Gold Nanoparticle Technology Overview
Direct Detection of Nucleic Acids
Chemistry
Applications
Bibliography
Request Information
Ultra-sensitive Protein Detection
Chemistry
Applications
Bibliography
Products
Verigene
®
System
Overview of the Verigene
®
Reader
Overview of the Verigene
®
Processor
Overview of a Verigene
®
Test Cartridge
Overview of the Verigene
®
System Workflow
Verigene
®
Nucleic Acid Tests
Genetics
Pharmacogenetics
Infectious diseases
Oncology
Investor Relations / Media
Investor Overview
Stock Information
Corporate Governance
Press Releases
Presentations
Annual Reports/Proxy
SEC Filings
Upcoming Events
Contact Us
Contact Request Form
Careers
Facilities Manager
SEC Filings
Form 8-K
NANOSPHERE INC filed this
Form 8-K
on 07/15/10
Document Outline
Entire Document (162.5 KB)
Subdocument 1 - 8-K - FORM 8-K
Page 1 - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Page 2 - Item 1.01. Entry into a Material Definitive Agreement.
Page 3 - SIGNATURES
Page 4 - EXHIBIT INDEX
Subdocument 2 - EX-10.1 - EXHIBIT 10.1
Page 1 - Exhibit 10.1
Page 2 - N/A
Page 3 - ARTICLE 2. GRANT OF RIGHTS
Page 4 - ARTICLE 3. COMMERCIALIZATION
Page 5 - The Wall Street Journal,
Page 6 - N/A
Page 7 - ARTICLE 7. CONFIDENTIALITY AND PUBLICATIONS
Page 8 - provided that
Page 9 - ARTICLE 8. REPRESENTATIONS, WARRANTIES AND COVENANTS
Page 10 - N/A
Page 11 - provided
Page 12 - ARTICLE 11. DISPUTE RESOLUTION
Page 13 - ARTICLE 12. MISCELLANEOUS
Page 14 - N/A
Page 15 - N/A
Page 16 - ,
Page 17 - APPENDIX A
Page 18 - N/A
Page 19 - APPENDIX B
Investor Overview
Stock Information
Corporate Governance
Press Releases
Presentations
Annual Reports/Proxy
SEC Filings
Upcoming Events
Print Page
E-mail Page
RSS News Feed
E-mail Alerts
